LexaGene Continues Vet Dx Market Push, Explores Sequencing Sample Prep for Microfluidic PCR Tech
The firm aims to commercialize its platform for infectious disease testing in the US by mid to late 2019, and continues to explore additional financing options.
LexaGene, Texas A&M Veterinary Dx Lab Collaborate on Pathogen Detection Testing
As part of the collaboration, Texas A&M veterinarians will send canine urine samples to LexaGene for testing on its LX6 pathogen detection instrument.
DoD Awards $10M to Consortium to ID New TB Drug Targets
The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.
Big Cat Genomes Reveal Phylogenetic History
With new and available genome sequences, investigators delved into phylogenetic patterns and adaptations in lions, leopards, tigers, snow leopards, and jaguars.
Circulating Maternal MicroRNAs Distinguish Infants Affected by Fetal Alcohol Syndrome
Researchers in the US and Ukraine built a microRNA-based classifier to categorize infants as affected or unaffected.